← Back to Search

Behavioural Intervention

Younger Cohort for Cognitive Functioning

N/A
Recruiting
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up through day 7
Awards & highlights

Study Summary

This trial will test whether a home-operated stimulator can improve cognitive performance in young and old adults.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up through day 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and up through day 7 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
System Usability Scale

Trial Design

2Treatment groups
Active Control
Group I: Younger CohortActive Control1 Intervention
Healthy individuals aged 18 - 55
Group II: Older CohortActive Control1 Intervention
Healthy individuals aged 56 - 85

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,655 Total Patients Enrolled
1 Trials studying Cognitive Functioning
17 Patients Enrolled for Cognitive Functioning

Media Library

Transcutaneous Vagal Nerve Stimulation (tVNS) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04484285 — N/A
Cognitive Functioning Research Study Groups: Younger Cohort, Older Cohort
Cognitive Functioning Clinical Trial 2023: Transcutaneous Vagal Nerve Stimulation (tVNS) Highlights & Side Effects. Trial Name: NCT04484285 — N/A
Transcutaneous Vagal Nerve Stimulation (tVNS) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04484285 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~11 spots leftby Apr 2025